Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

America's "Great Generic Wars" and the Canadian-European Trade Agreement

August 26, 2014

Tom Norton is watching with interest what the Canadians are about to visit on their generic industry, courtesy of a new international trade agreement.

TTIP: From Hot Tip to Oblivion?

August 18, 2014

The Transatlantic Trade and Investment Partnership (TTIP) was the hot tip for a 2014 success story. But as summer slides away, the latest read-out of progress suggests that rather than remaining a hot tip, TTIP is now risking oblivion...

Mind the (Generation) Gap: The Hunt for Talent in Asia-Pac

August 14, 2014

As more global pharma and medical device firms see their Asian businesses skyrocket, the search for strong talent in Asia-Pacific has never been more competitive, writes Susan Macdonald.

Social Media Struggles Continue

August 1, 2014

Tweeting limited, corrections okay, says FDA, as industry, regulators wrestle with the digital world. Our Washington Correspondent Jill Wechsler reports.

Brown University's Masters in Healthcare Leadership: A Mission to Transform

August 1, 2014

Mid-career students on Brown University's new program are challenged to remove the organizational silos that slow innovations in the delivery and financing of healthcare.

A Window on the Industry: The Emerging Pharma Leaders 2014

August 1, 2014

Pharm Exec's 2014 roster of emerging pharma leaders serves as a window on work in an industry that relies on human capital as the coinage of success, writes William Looney.

Emerging Pharma Leaders 2014

August 1, 2014

This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise—all binded by an underlying commitment to the patient.

Google Glass — A User's Guide in Healthcare

August 1, 2014

Three medical affairs experts review the capabilities of Google's latest technology for delivering information to healthcare professionals in the field.

Managing High-Priced, U.S. Biotech Rxs in Canada

July 30, 2014

As the "Sovaldi Saga" unfolds in the U.S., it's clear the situation will only deteriorate. But north of the border, it's striking how Canadian healthcare entities are managing a similar Sovaldi situation, writes Tom Norton.

ADVERTISEMENT

Click here